-
Science’s breakthrough of the year: HIV treatment as prevention
January 10, 2012 Editor 0
A clinical trial that revitalized HIV research tops the journal’s list of advances in 2011 The journal Science has lauded an eye-opening HIV study, known as HPTN 052, as the most important scientific breakthrough of 2011. This clinical trial demonstrated that people infected with HIV are 96 percent less likely to transmit the virus to their partners […]
More -
First results from Phase 3 trial show malaria vaccine candidate reduces the risk of malaria
October 18, 2011 Editor 0
First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months Seattle, 18 October 2011 — First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine […]
More -
Weakened malaria parasites form basis of new vaccine strategy
September 8, 2011 Editor 0
Using live but weakened malaria parasites as the basis of a vaccine represents a potentially encouraging anti-malaria strategy, according to results of follow-up animal studies performed after the conclusion of a recent clinical trial in humans.
More
